Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan

BACKGROUND: The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. This article describes the statistical analysis plan for this trial as an update to the published protoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Kashfia, Doré, Caroline J., Bunce, Catey, Larkin, Daniel F. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291687/
https://www.ncbi.nlm.nih.gov/pubmed/32532321
http://dx.doi.org/10.1186/s13063-020-04392-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291687/
https://www.ncbi.nlm.nih.gov/pubmed/32532321
http://dx.doi.org/10.1186/s13063-020-04392-1

Ejemplares similares